Literature DB >> 14973532

Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part B: Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction.

A Guay1, J Jacobson, R Munarriz, A Traish, L Talakoub, F Quirk, I Goldstein, R Spark.   

Abstract

Androgen insufficiency has been associated with decreased libido and arousal in postmenopausal women, but rarely has been evaluated in healthy premenopausal women. In all, 32 healthy premenopausal women were enrolled in this study, 18 with one or more complaints of sexual dysfunction and 14 without. Assays of ovarian and adrenal androgens were measured before and after ACTH stimulation. The women with complaints of sexual dysfunction had significantly lower adrenal androgens than did the control women. There were no differences in the basal ovarian androgens or cortisol levels. After ACTH, both groups stimulated cortisol as well as adrenal and ovarian androgens. In conclusion, premenopausal women with complaints of sexual dysfunction had lower adrenal androgen precursors and testosterone than age-matched control women without such complaints. Further study is required to determine how lower adrenal androgens contribute to female sexual dysfunction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14973532     DOI: 10.1038/sj.ijir.3901176

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  12 in total

1.  Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry.

Authors:  Micol S Rothman; Nichole E Carlson; Mei Xu; Christina Wang; Ronald Swerdloff; Paul Lee; Victor H H Goh; E Chester Ridgway; Margaret E Wierman
Journal:  Steroids       Date:  2010-11-09       Impact factor: 2.668

Review 2.  [Female sexual dysfunction].

Authors:  J B Korda
Journal:  Urologe A       Date:  2008-01       Impact factor: 0.639

Review 3.  The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.

Authors:  Sheryl A Kingsberg; Anita H Clayton; James G Pfaus
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

4.  Opioid analgesics suppress male gonadal function but opioid use in males and females does not correlate with symptoms of sexual dysfunction.

Authors:  Dana Wong; Dan P Gray; Mark Simmonds; Saifee Rashiq; Igor Sobolev; Donald W Morrish
Journal:  Pain Res Manag       Date:  2011 Sep-Oct       Impact factor: 3.037

5.  The role of salivary cortisol and DHEA-S in response to sexual, humorous, and anxiety-inducing stimuli.

Authors:  Lisa Dawn Hamilton; Cindy M Meston
Journal:  Horm Behav       Date:  2010-12-30       Impact factor: 3.587

6.  Effect of radiotherapy for rectal cancer on ovarian androgen production.

Authors:  J Segelman; C Buchli; A Svanström Röjvall; P Matthiessen; S Arver; M Bottai; M Ahlberg; R Jasuja; A Flöter-Rådestad; A Martling
Journal:  Br J Surg       Date:  2018-09-12       Impact factor: 6.939

Review 7.  Female sexual dysfunction.

Authors:  Erdogan Aslan; Michelle Fynes
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-11-01

8.  Chronic stress and sexual function in women.

Authors:  Lisa Dawn Hamilton; Cindy M Meston
Journal:  J Sex Med       Date:  2013-07-10       Impact factor: 3.802

9.  Comparing the effects of the second-and third-generation oral contraceptives on sexual functioning.

Authors:  Mahnaz Shahnazi; Somaye Bayatipayan; Azizeh Farshbaf Khalili; Fatemeh Ranjbar Kochaksaraei; Mohammad Asghari Jafarabadi; Kamala Gaza Banoi; Jila Nahaee
Journal:  Iran J Nurs Midwifery Res       Date:  2015 Jan-Feb

Review 10.  Lifestyles and sexuality in men and women: the gender perspective in sexual medicine.

Authors:  Daniele Mollaioli; Giacomo Ciocca; Erika Limoncin; Stefania Di Sante; Giovanni Luca Gravina; Eleonora Carosa; Andrea Lenzi; Emmanuele Angelo Francesco Jannini
Journal:  Reprod Biol Endocrinol       Date:  2020-02-17       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.